CoChat

Myostatin: A Skeletal Muscle Chalone

Open access
Lee, Se-Jin · 2023 · Annual Review of Physiology

The DOI matches its Crossref record; 145 of the 146 references it cites were found in a registry or an index.

Abstract

Myostatin (GDF-8) was discovered 25 years ago as a new transforming growth factor-β family member that acts as a master regulator of skeletal muscle mass. Myostatin is made by skeletal myofibers, circulates in the blood, and acts back on myofibers to limit growth. Myostatin appears to have all of the salient properties of a chalone, which is a term proposed over a half century ago to describe hypothetical circulating, tissue-specific growth inhibitors that control tissue size. The elucidation of the molecular, cellular, and physiological mechanisms underlying myostatin activity suggests that myostatin functions as a negative feedback regulator of muscle mass and raises the question as to whether this type of chalone mechanism is unique to skeletal muscle or whether it also operates in other tissues.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1146/annurev-physiol-012422-112116

Cites

145 of 145 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Regulation of muscle mass by myostatin (MSTN), activin A, and bone morphogenetic proteins (BMPs). Following proteolytic processing of the precursor protein, MSTN remains noncovalently bound to its N-terminal propeptide, which maintains MSTN in an inactive, latent state. The latent MSTN complex is activated by members of the BMP-1 family of metalloproteases: BMP-1, TLD (tolloid), TLL-1 (tolloid-like 1), and TLL-2. MSTN is also regulated extracellularly by other inhibitory binding proteins, including GASP-1 (growth and differentiation factor–associated serum protein-1), GASP-2, follistatin (FST), and FSTL-3 (follistatin-like 3) (also called FLRG or follistatin-related gene). Follistatin and FSTL-3 are also capable of binding and inhibiting activin A. LTBP-3 (latent TGF-β binding protein-3) may play a role in regulating the processing of the MSTN precursor protein. MSTN and activin A signal by binding initially to the activin type 2 receptors, ACVR2 (activin receptor type 2) and ACVR2B, which leads to engagement of the type 1 receptors, ALK4 (activin receptor–like kinase-4) and ALK5. ALK4 and ALK5 phosphorylate and activate the SMAD (SMA and MAD-related) proteins, SMAD2 and SMAD3, which form a complex with SMAD4 and act to inhibit muscle growth. Although the specific components utilized by BMPs in muscle have not been completely elucidated, BMPs are capable of binding to the type 1 receptors, ALK3 and ALK6, and then engaging the type 2 receptors, BMPR2 (bone morphogenetic protein receptor type 2), ACVR2, and ACVR2B. ALK3 and ALK6 phosphorylate and activate SMAD1, SMAD5, and SMAD8, which form a complex with SMAD4 and act to induce muscle growth. Components shown in green act to induce muscle growth, and components shown in pink act to inhibit muscle growth.
Figure 1 Regulation of muscle mass by myostatin (MSTN), activin A, and bone morphogenetic proteins (BMPs). Following proteolytic processing of the precursor protein, MSTN remains noncovalently bound to its N-terminal propeptide, which maintains MSTN in an inactive, latent state. The latent MSTN complex is activated by members of the BMP-1 family of metalloproteases: BMP-1, TLD (tolloid), TLL-1 (tolloid-like 1), and TLL-2. MSTN is also regulated extracellularly by other inhibitory binding proteins, including GASP-1 (growth and differentiation factor–associated serum protein-1), GASP-2, follistatin (FST), and FSTL-3 (follistatin-like 3) (also called FLRG or follistatin-related gene). Follistatin and FSTL-3 are also capable of binding and inhibiting activin A. LTBP-3 (latent TGF-β binding protein-3) may play a role in regulating the processing of the MSTN precursor protein. MSTN and activin A signal by binding initially to the activin type 2 receptors, ACVR2 (activin receptor type 2) and ACVR2B, which leads to engagement of the type 1 receptors, ALK4 (activin receptor–like kinase-4) and ALK5. ALK4 and ALK5 phosphorylate and activate the SMAD (SMA and MAD-related) proteins, SMAD2 and SMAD3, which form a complex with SMAD4 and act to inhibit muscle growth. Although the specific components utilized by BMPs in muscle have not been completely elucidated, BMPs are capable of binding to the type 1 receptors, ALK3 and ALK6, and then engaging the type 2 receptors, BMPR2 (bone morphogenetic protein receptor type 2), ACVR2, and ACVR2B. ALK3 and ALK6 phosphorylate and activate SMAD1, SMAD5, and SMAD8, which form a complex with SMAD4 and act to induce muscle growth. Components shown in green act to induce muscle growth, and components shown in pink act to inhibit muscle growth.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 145 references

Research works printed but not linked: 5

  1. Swann MM., 1958, Cancer Res, 18, 1118
  2. Dall'Olio S, 2010, J. Biomed. Biotechnol., 542945
  3. 10.1152/japplphysiol.00866.2009 · DOI
  4. Woodhouse L, 2016, J. Frailty Aging, 5, 62
  5. Bullough WS., 1965, Cancer Res, 25, 1683

Cited by

See all 84

Metadata

Authors
Lee, S.-J.
Affiliations
University of Connecticut (US)
Corresponding author
Lee, Se-Jin
Venue
Annual Review of Physiology
Published
2023-02-10
Volume
85
Issue
1
Pages
269-291
ISSN
  • 0066-4278 (ISSN-L)
  • 1545-1585
OpenAlex
W4306918340
Cited by
84
References
146
Citations by year
2026: 25 · 2025: 24 · 2024: 23 · 2023: 12
FWCI
1.54
Type
journal article
Language
en
Open access
Locations
  • Annual Review of Physiology (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • PubMed Central (acceptedVersion, cc-by)
  • The Mouseion at the JAXlibrary (Jackson Laboratory) (submittedVersion, cc-by)
Funders
  • Johns Hopkins University
  • National Institutes of Health
  • National Institute on Aging (R01AG052962)
  • National Institute of Arthritis and Musculoskeletal and Skin Diseases (R01AR060636, R01AR081659)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Muscle Physiology and Disorders
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › TGF-β signaling in diseases
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetics and Physical Performance
Keywords
myostatin, chalone, skeletal muscle mass, transforming growth factor-beta family, negative feedback regulation, muscle fibers
MeSH terms
Humans, Transforming Growth Factor beta, Muscle, Skeletal, Chalones, Myostatin

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Myostatin: A Skeletal Muscle Chalone. https://app.cochat.ai/papers/10.1146/annurev-physiol-012422-112116
The paper
Lee, S.-J. (2023). Myostatin: A Skeletal Muscle Chalone. Annual Review of Physiology. https://doi.org/10.1146/annurev-physiol-012422-112116

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.